Hypertrophic cardiomyopathy epidemiology and demographics

Hypertrophic Cardiomyopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypertrophic Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypertrophic cardiomyopathy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypertrophic cardiomyopathy epidemiology and demographics
CDC on Hypertrophic cardiomyopathy epidemiology and demographics
Hypertrophic cardiomyopathy epidemiology and demographics in the news
Blogs on Hypertrophic cardiomyopathy epidemiology and demographics
Directions to Hospitals Treating Hypertrophic cardiomyopathy
Risk calculators and risk factors for Hypertrophic cardiomyopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Epidemiology and Demographics

Incidence

• The incidence/prevalence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals worldwide.
• In [year], the incidence/prevalence of Hypertrophic cardiomyopathy was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

• The incidence/prevalence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals worldwide.
• In [year], the incidence/prevalence of Hypertrophic cardiomyopathy was estimated to be [number range] cases per 100,000 individuals worldwide.
• The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

• In [year], the incidence of Hypertrophic cardiomyopathy is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
• The case-fatality rate/mortality rate of Hypertrophic cardiomyopathy is approximately [number range].

Age

• Patients of all age groups may develop Hypertrophic cardiomyopathy.
• The incidence of Hypertrophic cardiomyopathy increases with age; the median age at diagnosis is [#] years.
• Hypertrophic cardiomyopathy commonly affects individuals younger than/older than [number of years] years of age.
• [Chronic disease name] is usually first diagnosed among [age group].
• [Acute disease name] commonly affects [age group].

Race

• There is no racial predilection to Hypertrophic cardiomyopathy.
• Hypertrophic cardiomyopathy usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop Hypertrophic cardiomyopathy.

Gender

• Hypertrophic cardiomyopathy affects men and women equally.
• [Gender 1] are more commonly affected by Hypertrophic cardiomyopathy than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

• The majority of Hypertrophic cardiomyopathy cases are reported in [geographical region].

• Hypertrophic cardiomyopathy is a common/rare disease that tends to affect [patient population 1] and [patient population 2].